Table 1 Clinical characteristics of reports with Dex from the FAERS database (2010 Q2-2024 Q1)
Characteristics | Number of reports (%) |
|---|---|
Gender | Â |
 Female | 576 (36.27) |
 Male | 657 (41.37) |
 Unknown | 355 (22.36) |
Age (years) | Â |
 <18 | 9 (0.57) |
 18–60 | 224 (14.11) |
 >60 | 426 (26.83) |
 Unknown | 929 (58.50) |
Reporter | Â |
 Physician | 818 (51.51) |
 Consumer | 466 (29.35) |
 Pharmacist | 161 (10.14) |
 Other health-professional | 132 (8.31) |
 Lawyer | 2 (0.13) |
 Unknown | 9 (0.57) |
Reported regions | Â |
 United States | 623 (39.23) |
 Europe | 444 (27.96) |
 Australia | 54 (3.40) |
 Turkey | 37 (2.33) |
 India | 34 (2.14) |
 China | 32 (2.02) |
 South Africa | 30 (1.88) |
Indications | Â |
 Diabetic macular edema | 249 (15.68) |
 Retinal vein occlusion | 244 (15.37) |
 Uevitis | 116 (7.30) |
 Macular edema without reported cause | 321 (20.21) |
 Others | 127 (8.00) |
 Unknown | 531 (33.44) |
Incidence of serious outcomes | Â |
 Hospitalization | 161 (12.76) |
 Disability | 66 (5.23) |
 Death | 60 (4.75) |
 Life threatening | 3 (0.24) |
Onset time of events (days) | Â |
 <7 | 279 (30.73) |
 7–30 | 84 (9.25) |
 >30 | 108 (11.89) |
 Unknown | 437 (48.13) |